R&D | April 17, 2026
Revvity aims to accelerate breakthroughs in cancer research
Revvity is positioning its technologies as a connected engine for discovery
Revvity is positioning its technologies as a connected engine for discovery
The company reported net revenue of SEK 13.5 million for the full year 2025
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
Former Wavemaker executive to lead media strategy and digital transformation agenda
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
Subscribe To Our Newsletter & Stay Updated
